Paul A. Friedman

Overview

Paul A. Friedman received an average of $3.7M in compensation at Synta Pharmaceuticals from 2016 to 2018 and an average of $2.3M at Incyte from 2007 to 2014.

Related executives

We found 26 more executives who work or worked at Synta Pharmaceuticals and Incyte.

Hervé Hoppenot

Incyte

Chief Executive Officer

Steven Stein

Incyte

Chief Medical Officer

Wenqing Yao

Incyte

Executive Vice President, Head of Discovery Chemistry

Reid Huber

Incyte

Chief Scientific Officer

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

Maria Pasquale

Incyte

General Counsel

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

David Gryska

Incyte

Chief Financial Officer

News

You may also like